Navigation Links
Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test
Date:3/30/2009

e number of patients at risk for C. difficile infection is substantial. At present, the incidence of infection has reached epidemic proportions. Recently-released results from the "National Prevalence Study of Clostridium difficile in US Healthcare Facilities" indicate that the rate of infection, or colonization, is 6.5 to 20 times greater than previous estimates.

The C. DIFF QUIK CHEK COMPLETE(TM) test offered by Inverness Medical is the only device that simultaneously detects both C. difficile glutamate dehydrogenase (GDH) and C. difficile toxins A and B in one simple assay. It can be used for screening while also confirming the presence of toxigenic C. difficile strains. The test provides results in less than 30 minutes from fecal samples, enabling rapid diagnosis and initiation of appropriate patient management. With use of a C. difficile rapid test, patients can be effectively isolated at an earlier stage of illness, reducing the risk of cross contamination and widespread outbreaks.

The C. difficile antigen glutamate dehydrogenase (GDH) used in the test is common to all strains of C. difficile and has been identified as an excellent screening marker for the infection. The new C. DIFF QUIK CHEK COMPLETE(TM) test, developed and manufactured by TECHLAB(R), Inc. in Blacksburg, VA, provides a more complete picture of the patient's disease state within one single test format with quicker time to results and higher negative predictive value (less false negative results) when compared to alternative existing testing methods.

About Inverness

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as w
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Inverness Medical Innovations to Pay April Series B Dividend in Additional Shares of Series B Stock
2. Inverness Medical Innovations Agrees to Acquire Second Territory Rapid Diagnostics Business of ACON
3. Inverness Medical Innovations Announces Fourth Quarter 2008 Results
4. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET February 18, 2009 to Discuss Fourth Quarter 2008 Results
5. James Roosevelt, Jr. Joins Inverness Medical Innovations Board of Directors
6. Inverness Medical Innovations to Present at the 2009 UBS Global Healthcare Services Conference on February 10, 2009
7. Inverness Medical Innovations Presents the pima(TM) Point-of-Care CD4 Instrument at ICASA 2008
8. Inverness Medical Innovations to Participate at JP Morgan Healthcare Conference on January 13, 2009
9. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
10. Inverness Medical Innovations to Present at RBC Capital Markets 2008 Healthcare Conference on December 11, 2008
11. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... (PRWEB) March 06, 2015 “ Pokemini ” ... which features the latest and coolest mobile applications on the ... expert and host of NewsWatch, conducted the app review and ... game. , Over the last couple of years, mobile ... to the game. For example, Candy Crush allows users to ...
(Date:3/6/2015)... Ticket Down is a reputable source for ... the Moda Center. After being away from the touring ... no signs of letting up on his “Garth Brooks World ... wife, Trisha Yearwood, to venues around the United States. The ... acclaimed tour to the Moda Center in Portland, OR. The ...
(Date:3/6/2015)... As the Muscular Dystrophy Association continues to enhance its ... two new Scientific Program Officers, Amanda Haidet-Phillips, Ph.D and ... Pavlath, Ph.D, who joined MDA late last year as ... will lead MDA as it accelerates new front-line discovery ... of neuromuscular and motor neuron diseases. , ...
(Date:3/6/2015)... CA (PRWEB) March 06, 2015 US ... of three Maryland camps – two non-contact specialty camps ... be run by Perfect Performance Training, located at Bowie ... focus on developing position specific skills, speed and strength ... hosted at Salisbury University with Marvin Graves, former quarterback ...
(Date:3/6/2015)... California (PRWEB) March 06, 2015 Johnson ... million jury verdict on March 5, 2015 in Superior ... According to court documents, a jury of 12 awarded ... suffered from being implanted with an Ethicon TVT Abbrevo ... nine men and three women also awarded $5 million ...
Breaking Medicine News(10 mins):Health News:A Kawaii Social Game was Featured on NewsWatch Television on February 26, 2015 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 2Health News:Garth Brooks Tickets in Portland, OR at the Moda Center: Ticket Down Slashes Garth Brooks Ticket Prices at the Moda Center in Portland 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 2Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 3Health News:MDA Adds Muscle Disease and ALS Leaders to Research Team 4Health News:US Sports Camps to Host Three New Football Camps in Maryland 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 2Health News:Johnson & Johnson Hit with $5.7 Million Verdict in Pelvic Mesh Trial Announces Matthews & Associates Law Firm 3
... for first time treatment of advanced lung cancer in ... randomised study on lung cancer patients led by Dr.Alan ... at Vanderbilt-Ingram Cancer Center. ,Nearly 900 patients ... the trial. None of them had received any previous ...
... the world today, Britain had to face the embarrassment of ... week. //In a recent report by CABE it was brought ... population can be declared obese and overweight. ,The ... headquarters in London works towards improving people's quality of life ...
... to investigate a botched cataract surgery camp at the Guwahati ... ,Health Minister Himanta Biswa Sarma said the enquiry would be ... and was expected to submit the report in three months. ... hence instituted a judicial probe to fix responsibility for the ...
... Virus type C (GBV-C) protects against HIV infection is now ... Iowa// City Health Care System and the University of Iowa ... growing in cell models. ,The team found that ... NS5A greatly slows down HIV from replicating in cells grown ...
... Hospital have developed a revolutionary treatment for dementia.// ... Research Centre George Razay merely merely draining fluid from ... 5000 Tasmanians are affected by dementia and the figure ... ,20 patients, equal number of men and women ...
... In order to restrict the use animals for the ... new techniques are being developed by researchers at the ... as a financial grant. ,Gauging the carcinogenic effects ... which further necessitates the use of live animals to ...
Cached Medicine News:Health News:Judicial Probe Ordered for Botched Eye Surgery Camp 2Health News:Study IDs Protein That Inhibits HIV From Growing In Cell Cultures 2Health News:Study IDs Protein That Inhibits HIV From Growing In Cell Cultures 3Health News:Grant Encourages Drug Testing Sans Animals 2
(Date:3/5/2015)...  BioPhotas, Inc., an FDA registered medical device manufacturer ... to treat skin, muscle and joint conditions, today announced ... to provide BioPhotas, flagship product, the Celluma, ... Commenting on the alliance, Patrick ... Celluma at the Warrior Hope and Care Center had ...
(Date:3/5/2015)... -- CANTEL MEDICAL CORP. (NYSE: CMN ) will ... 2015 on Thursday, March 12 before the market opens, and ... AM ET. To participate in the conference ... the beginning of the call. If you are unable to ... from Thursday, March 12, 2015 through midnight on May 12, ...
(Date:3/5/2015)... , March 5, 2015   ndd Medical ... testing (PFT) that employs precise ultrasound technology, announced that ... event held by the San Antonio Pulmonary Fibrosis Support ... (ILD) or pulmonary fibrosis (PF), as well as those ... a footprint of a mere 12 square inches, EasyOne ...
Breaking Medicine Technology:BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 2BioPhotas, Inc. and the Semper Fi Fund Work Together to Provide Pain Relief to Injured Service Members 3Cantel Medical Corp. To Hold Conference Call To Discuss Results For Its Second Quarter Ended January 31, 2015 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 2ndd Medical Technologies' Mobile Pulmonary Function Testing Helps Combat Pulmonary Fibrosis 3
... 22, 2010 Pfizer Inc (NYSE: PFE ... to both the United States Food and Drug Administration ... the use of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine ... and older for the prevention of pneumococcal disease caused ...
... Dec. 22, 2010 Haemonetics Corporation (NYSE: ... Chief Executive Officer, will present at the J.P. Morgan ... 2011 at 1:30 pm Pacific time.  The ... at http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=HAE .  The webcast ...
Cached Medicine Technology:Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 2Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 3Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 4Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 5
The cordless Simon Dermatome with rechargeable battery is used to harvest split-thickness skin grafts and for debridement....
Forceps with round handle, straight...
Castroviejo microscopic needle holder...
Microscopic scissors, curved...
Medicine Products: